NEW YORK – NeoGenomics said on Thursday that it has partnered with biopharmaceutical service provider Parexel to advance the application of precision medicine in clinical trials.
NEW YORK – NeoGenomics said on Thursday that it has partnered with biopharmaceutical service provider Parexel to advance the application of precision medicine in clinical trials.
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.